BCL2 and hepatocellular carcinoma: Apoptosis is a common pathway that mediates the anti-proliferative activity of multiple chemotherapeutic drugs, and inhibition of apoptosis is known to contribute to MDR for HCC cells in which anti-apoptotic factors, such as Nuclear factor-κB and BCL-2 are aberrantly expressed [40].